Albumin and immunoglobulin

· Instituto Grifols, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albumin and immunoglobulin, covering 2019-07-31 to 2019-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease [Phase 2, Phase 3]